SCHEMBL6175890

SCHEMBL6175890

CC(c1ccnc2c(N(C)C)cccc12)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
EPHX1 P07099 1/20 0.33
EPHX2 P34913 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
ACP1 P24666 1/20 0.33
GPR139 Q6DWJ6 2/20 0.33
HRH4 Q9H3N8 1/20 0.33
CXCR3 P49682 2/20 0.32
RUNX1 Q01196 1/20 0.32
TRPV4 Q9HBA0 1/20 0.32
PDE2A O00408 1/20 0.31
CASR P41180 2/20 0.31
SLC40A1 Q9NP59 1/20 0.31
GRM5 P41594 1/20 0.31
GRM1 Q13255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172286 0.89 LMNA (0.41) LMNAPOLBL3MBTL1NPSR1GPR139
SCHEMBL6171030 0.88 LMNA (0.40) LMNAPOLBL3MBTL1NPSR1GPR139
SCHEMBL6174955 0.88 LMNA (0.40) LMNAPOLBL3MBTL1NPSR1GPR139
SCHEMBL6171217 0.87 GPR139 (0.43) LMNAGPR139
SCHEMBL6174880 0.86 IGF1R (0.36) LMNAPOLBL3MBTL1NPSR1TRPV4
SCHEMBL6172559 0.83 LMNA (0.37) LMNAPOLBL3MBTL1NPSR1GPR139
SCHEMBL6173959 0.77 LMNA (0.40) LMNAPOLBL3MBTL1CXCR3TRPV4
SCHEMBL6173699 0.77 LMNA (0.44) LMNAPOLBL3MBTL1ACP1GPR139
SCHEMBL6176406 0.74 LMNA (0.39) LMNAPOLBL3MBTL1CXCR3
SCHEMBL6175238 0.74 IGF1R (0.43) LMNAPOLBL3MBTL1NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed